Capio Biosciences is a company that develops oncology diagnostics. It works on a platform called CapioCyte for the capture of circulating tumor cells from whole blood. CapioCyte is also able to provide enriched circulating tumor cells for post-capture molecular analysis such as FISH, RNA-Seq, and NGS.